How targeting tumor-mediated immune suppression has led to novel cancer immunotherapeutics

Explain how this occurs and describe how targeting tumor-mediated immune suppression has led to novel cancer immunotherapeutics. Neoplastic cells typically evade immunosurveillance.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *